Balance sheet of CORONA Remedies is strong.
But short term working capital might become an issue for this company.

The net debt of CORONA Remedies is decreasing.
Latest net debt of CORONA Remedies is -₹73.15 Crs as of Mar-25.
This is less than Mar-24 when it was -₹3.94 Crs.

Yes, profit is increasing.
The profit of CORONA Remedies is ₹149 Crs for Mar 2025, ₹90.5 Crs for Mar 2024 and ₹84.93 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
CORONA Remedies latest dividend payout ratio is 29.92% and 3yr average dividend payout ratio is 24.96%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress